Proto Labs Inc. (PRLB) stock down despite upgrade at Zacks Investment Research

Zacks Investment Research (Proto Labs Inc.: NYSE) shares fell back in value Wednesday Dec 28 with lighter trade volume than normal after a number of analysts weighed in on the investing value of the stock with a upgraded rating.

Meanwhile, U.S. stocks were little changed on Wednesday, as investors found few reasons to keep pushing shares higher towards the 20,000 mark.

The Dow Jones Industrial Average DJIA, -0.11% rose 3.1 points to 19,949, essentially unchanged on the day. The S&P 500 SPX, -0.39% lost 3 points, or 0.1%, to 2,266 while the Nasdaq Composite Index COMP, -0.59% slipped 6.4 points, or 0.1%, to 5,482.

Analysts at Zacks Investment Research upgraded shares of Zacks Investment Research (Proto Labs Inc.: NYSE) from Sell to Hold today. Zacks Investment Research currently has a rating of Hold on the shares. The one-year price target of $45.40 is lower than the opening price of $53.15, that has caused a fair amount of other analysts to issue statements on the company recently. Looking back over the last 52 weeks, Proto Labs Inc. stock has a high of $82.06. Typically, after analysts assign an upgrade report on a stock, they will subsequently issue periodic revisions, usually followed by a price target change.

Zacks Investment Research (Proto Labs Inc.: NYSE) shares last traded at $52.45, which represents a drop of $0.50 per share or -0.94% from the previous closing price. Opening at $53.15, they varied from $52.45 and $53.70 throughout the day.

Zacks Investment Research (Proto Labs Inc.: NYSE) currently has a market cap of 1.39B.

Zacks Investment Research (Proto Labs Inc.: NYSE) Average Daily Trading Volume

9,708 shares traded hands yesterday, below the norm, out of a total float 24,449,000. Look for trading volume to pick up in the coming days as investors often use swings in trading volume to determine large volume accumulation or distribution by institutional investors.

As with all possible breakouts, investors watch for volume to be at least 40%-50% above normal on the breakout to demonstrate that fund managers and other professional investors are jumping in.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors retain substantial teams of analysts that investigate thousands of stocks, so it is good corroboration to see them taking a postion in a stock you’re considering.

Zacks Investment Research (Proto Labs Inc.: NYSE) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By spotting trends, moving averages allow traders to make those trends work in their favor and increase the number of winning trades.

Trades for Zacks Investment Research (Proto Labs Inc.: NYSE) have ranged from $43.10 – 82.06, and the stock now has a 50-day MA of $52.57 and 200-day MA of $55.51. Today’s last price is 36.08%% under the 52 week high of $82.06.

Indeed, earnings growth is among the most important things to look at in regards to stock investing and, accordingly, investors watch for companies that have been successful at growing their earnings by at least 25% over 3 consecutive years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *